Moneycontrol
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Sun Pharmaceutical Industries

Sun Pharmaceutical Industries

BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 20, 16:00
505.40
-3.4 (-0.67%)
VOLUME 127,619
LIVE
NSE
Apr 20, 15:59
505.30
-3.9 (-0.77%)
VOLUME 4,431,085
News on Sun Pharmaceutical Industries
Select Year: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Sun Pharma Q4 PAT may dip 18.1% YoY to Rs. 1,000 cr: HDFC Securities

12.49 pm | 20 Apr 2018 |  Source: Moneycontrol.com

Net Sales are expected to decrease by 5.1 percent Y-o-Y (up 1.8 percent Q-o-Q) to Rs. 6,780 crore, according to HDFC Securities....

Sun Pharma Q4 PAT may dip 39.1% YoY to Rs. 745.2 cr: Edelweiss

6.50 pm | 16 Apr 2018 |  Source: Moneycontrol.com

Net Sales are expected to decrease by 6.4 percent Y-o-Y (up 0.4 percent Q-o-Q) to Rs. 6,676.9 crore, according to Edelweiss....

Pharma Q4 earnings preview: Tough quarter; US pricing pressure, domestic sales recovery hold key

5.53 pm | 12 Apr 2018 |  Source: Moneycontrol.com

Analysts predict the last quarter of FY18 to be mixed bag with revenues expected to remain almost flat to a growth of lower single digit on year-on-ye...

Hold Sun Pharmaceuticals; target of Rs 480: Edelweiss

5.03 pm | 05 Apr 2018 |  Source: Moneycontrol.com

Edelweiss recommended hold rating on Sun Pharmaceuticals with a target price of Rs 480 in its research report dated April 05, 2018....

Buy Sun Pharmaceutical Industries; target of Rs 633: KR Choksey

4.15 pm | 23 Mar 2018 |  Source: Moneycontrol.com

KR Choksey is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 633 in its research report da...

Top buzzing midcap stocks to trade today 

1.25 pm | 22 Mar 2018 |  Source: CNBC-TV18

Here are some of the top buzzing midcap stocks picked by CNBCTV18's analysts in trade today. Keep an eye on Sun Pharmaceutical, Binani Industries,...

Sun Pharma gains 3% on USFDA approval for psoriasis drug Ilumya 

9.26 am | 22 Mar 2018 |  Source: Moneycontrol.com

Ilumya is used for the treatment of the most common plaque psoriasis – a chronic immune disease that appears on the skin....

News highlights of the day: BJP says Cambridge Analytica's footprints seen in Congress's Gujarat campaign

7.21 am | 22 Mar 2018 |  Source: Moneycontrol.com

This blog will keep track of key global and local developments impacting business and markets through the day. Important local and global political de...

Sun Pharma gets US FDA nod for its specialty psoriasis drug Ilumya

8.42 pm | 21 Mar 2018 |  Source: Moneycontrol.com

Analysts expect the company to launch the drug in next three months with a peak sale potential of USD 300 million....

Hold Sun Pharmaceutical Industries; target of Rs 600: Sharekhan

4.44 pm | 06 Mar 2018 |  Source: Moneycontrol.com

Sharekhan has recommended hold rating on Sun Pharmaceutical Industries with a target price of Rs 600 in its research report dated March 06, 2018....

Buy Sun Pharma; target of Rs 675: Motilal Oswal

4.13 pm | 06 Mar 2018 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 675 in its research report dated March 06, 20...

Sun Pharma Q3 profit falls 75% to Rs 365 cr on tax cost; operating income tanks 41% 

4.05 pm | 14 Feb 2018 |  Source: Moneycontrol.com

Revenue from operations slipped 16 percent to Rs 6,653.23 crore compared to Rs 7,925.11 crore in year-ago....

Buy Sun Pharmaceutical Industries; target of Rs 579: Khambatta Securities

3.45 pm | 23 Nov 2017 |  Source: Moneycontrol.com

Khambatta Securities is bullish on Sun Pharmaceutical Industries has recommended buy rating on the stock with a target price of Rs 579 in its research...

Sun Pharma Q2 profit seen down 64% to Rs 802 cr lower revenue, operating income

12.14 pm | 14 Nov 2017 |  Source: CNBC-TV18

Revenue during the quarter is seen declining 17 percent to Rs 6,861 crore compared with Rs 8,265 crore in same quarter last fiscal, according to avera...

1 2 3
Quick Links for Sun Pharmaceutical Industries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.